期刊
TRENDS IN PARASITOLOGY
卷 36, 期 7, 页码 582-591出版社
CELL PRESS
DOI: 10.1016/j.pt.2020.04.012
关键词
-
类别
资金
- European Research Council (ERC) [SCHISTO_PERSIST_680088]
- GCRF Medical Research Council (MRC) Foundation award [MR/P025447/1]
- Engineering and Physical Sciences Research Council (EPSRC) [EP/R01437X/1]
- Thrasher Research Fund [12440]
- Wellcome Trust [108061/Z/15/Z]
- National Institute for Health Research (NIHR) Global Health Research programme [16/136/33]
- National Institutes of Health (NIH) [AI110238]
- Darwin Trust of Edinburgh
- Wellcome Trust [108061/Z/15/Z] Funding Source: Wellcome Trust
- EPSRC [EP/R01437X/1] Funding Source: UKRI
- MRC [MR/P025447/1] Funding Source: UKRI
Despite accelerating progress towards schistosomiasis control in sub-Saharan Africa, several age groups have been eclipsed by current treatment and monitoring strategies that mainly focus on school-aged children. As schistosomiasis poses a threat to people of all ages, unfortunate gaps exist in current treatment coverage and associated monitoring efforts, preventing subsequent health benefits to preschool-aged children as well as certain adolescents and adults. Expanding access to younger ages through the forthcoming pediatric praziquantel formulation and improving treatment coverage in older ages is essential. This should occur alongside formal inclusion of these groups in large-scale monitoring and evaluation activities. Current omission of these age groups from treatment and monitoring exacerbates health inequities and has long-term consequences for sustainable schistosomiasis control.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据